Methods and instruments to evaluate cognitive function in chronic pain patients

a systematic review

Begoña Ojeda, Inmaculada Failde, María Dueñas, Alejandro Salazar, Christopher Eccleston

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Objective. We aimed to systematically review the methods and instruments used to evaluate cognitive function in chronic pain (CP) patients. Methods. A sensitive search strategy was designed using five databases. Based on the objectives and methodology, we selected cross-sectional studies on adults with chronic non-cancer pain in which cognitive function was assessed using validated instruments. The characteristics of the subjects, control groups, and other variables that might affect cognitive function, and the instruments used, were extracted from each article. Results. In the 42 articles identified, 53 instruments were used to assess cognitive function. Chronic pain criteria were defined in 83.3% of the articles and more than half (57.1%) included single diagnosis samples, with fibromyalgia being the most frequent studied (75%). Patients with prior cognitive impairment were excluded in 61.9% of the studies, and a control group was included in 64.3% of the studies. In most cases potential confounding variables were evaluated. More than 14% of the studies used self-report measures, and 73.8% used neuropsychological instruments, particularly for assessing attention (30%) and memory (27.5%). None of the instruments were specifically validated for pain patients and only five studies analyzed the psychometric properties of the instruments. Conclusions. Various instruments and methods were used to assess cognitive function in CP patients, particularly fibromyalgia patients, but also other cohorts with well-defined CP. The instruments used had been validated, but not for pain populations, thus they require specific adaptation and validation to be used in CP patients. Certain recommendations are made in order to improve the evaluation of cognitive function in these patients.

Original languageEnglish
Pages (from-to)1465-1489
Number of pages25
JournalPain Medicine
Volume17
Issue number8
DOIs
Publication statusPublished - 1 Aug 2016

Fingerprint

Chronic Pain
Cognition
Fibromyalgia
Pain
Control Groups
Confounding Factors (Epidemiology)
Psychometrics
Self Report
Cross-Sectional Studies
Databases
Population

Keywords

  • Assessment
  • Chronic pain
  • Cognitive function
  • Neuropsychological testing
  • Self-report questionnaire

Cite this

Methods and instruments to evaluate cognitive function in chronic pain patients : a systematic review. / Ojeda, Begoña; Failde, Inmaculada; Dueñas, María; Salazar, Alejandro; Eccleston, Christopher.

In: Pain Medicine, Vol. 17, No. 8, 01.08.2016, p. 1465-1489.

Research output: Contribution to journalReview article

Ojeda, Begoña ; Failde, Inmaculada ; Dueñas, María ; Salazar, Alejandro ; Eccleston, Christopher. / Methods and instruments to evaluate cognitive function in chronic pain patients : a systematic review. In: Pain Medicine. 2016 ; Vol. 17, No. 8. pp. 1465-1489.
@article{899e9afb1604404993c82f7bb96006f2,
title = "Methods and instruments to evaluate cognitive function in chronic pain patients: a systematic review",
abstract = "Objective. We aimed to systematically review the methods and instruments used to evaluate cognitive function in chronic pain (CP) patients. Methods. A sensitive search strategy was designed using five databases. Based on the objectives and methodology, we selected cross-sectional studies on adults with chronic non-cancer pain in which cognitive function was assessed using validated instruments. The characteristics of the subjects, control groups, and other variables that might affect cognitive function, and the instruments used, were extracted from each article. Results. In the 42 articles identified, 53 instruments were used to assess cognitive function. Chronic pain criteria were defined in 83.3{\%} of the articles and more than half (57.1{\%}) included single diagnosis samples, with fibromyalgia being the most frequent studied (75{\%}). Patients with prior cognitive impairment were excluded in 61.9{\%} of the studies, and a control group was included in 64.3{\%} of the studies. In most cases potential confounding variables were evaluated. More than 14{\%} of the studies used self-report measures, and 73.8{\%} used neuropsychological instruments, particularly for assessing attention (30{\%}) and memory (27.5{\%}). None of the instruments were specifically validated for pain patients and only five studies analyzed the psychometric properties of the instruments. Conclusions. Various instruments and methods were used to assess cognitive function in CP patients, particularly fibromyalgia patients, but also other cohorts with well-defined CP. The instruments used had been validated, but not for pain populations, thus they require specific adaptation and validation to be used in CP patients. Certain recommendations are made in order to improve the evaluation of cognitive function in these patients.",
keywords = "Assessment, Chronic pain, Cognitive function, Neuropsychological testing, Self-report questionnaire",
author = "Bego{\~n}a Ojeda and Inmaculada Failde and Mar{\'i}a Due{\~n}as and Alejandro Salazar and Christopher Eccleston",
year = "2016",
month = "8",
day = "1",
doi = "10.1093/pm/pnv077",
language = "English",
volume = "17",
pages = "1465--1489",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "VICER Publishing",
number = "8",

}

TY - JOUR

T1 - Methods and instruments to evaluate cognitive function in chronic pain patients

T2 - a systematic review

AU - Ojeda, Begoña

AU - Failde, Inmaculada

AU - Dueñas, María

AU - Salazar, Alejandro

AU - Eccleston, Christopher

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objective. We aimed to systematically review the methods and instruments used to evaluate cognitive function in chronic pain (CP) patients. Methods. A sensitive search strategy was designed using five databases. Based on the objectives and methodology, we selected cross-sectional studies on adults with chronic non-cancer pain in which cognitive function was assessed using validated instruments. The characteristics of the subjects, control groups, and other variables that might affect cognitive function, and the instruments used, were extracted from each article. Results. In the 42 articles identified, 53 instruments were used to assess cognitive function. Chronic pain criteria were defined in 83.3% of the articles and more than half (57.1%) included single diagnosis samples, with fibromyalgia being the most frequent studied (75%). Patients with prior cognitive impairment were excluded in 61.9% of the studies, and a control group was included in 64.3% of the studies. In most cases potential confounding variables were evaluated. More than 14% of the studies used self-report measures, and 73.8% used neuropsychological instruments, particularly for assessing attention (30%) and memory (27.5%). None of the instruments were specifically validated for pain patients and only five studies analyzed the psychometric properties of the instruments. Conclusions. Various instruments and methods were used to assess cognitive function in CP patients, particularly fibromyalgia patients, but also other cohorts with well-defined CP. The instruments used had been validated, but not for pain populations, thus they require specific adaptation and validation to be used in CP patients. Certain recommendations are made in order to improve the evaluation of cognitive function in these patients.

AB - Objective. We aimed to systematically review the methods and instruments used to evaluate cognitive function in chronic pain (CP) patients. Methods. A sensitive search strategy was designed using five databases. Based on the objectives and methodology, we selected cross-sectional studies on adults with chronic non-cancer pain in which cognitive function was assessed using validated instruments. The characteristics of the subjects, control groups, and other variables that might affect cognitive function, and the instruments used, were extracted from each article. Results. In the 42 articles identified, 53 instruments were used to assess cognitive function. Chronic pain criteria were defined in 83.3% of the articles and more than half (57.1%) included single diagnosis samples, with fibromyalgia being the most frequent studied (75%). Patients with prior cognitive impairment were excluded in 61.9% of the studies, and a control group was included in 64.3% of the studies. In most cases potential confounding variables were evaluated. More than 14% of the studies used self-report measures, and 73.8% used neuropsychological instruments, particularly for assessing attention (30%) and memory (27.5%). None of the instruments were specifically validated for pain patients and only five studies analyzed the psychometric properties of the instruments. Conclusions. Various instruments and methods were used to assess cognitive function in CP patients, particularly fibromyalgia patients, but also other cohorts with well-defined CP. The instruments used had been validated, but not for pain populations, thus they require specific adaptation and validation to be used in CP patients. Certain recommendations are made in order to improve the evaluation of cognitive function in these patients.

KW - Assessment

KW - Chronic pain

KW - Cognitive function

KW - Neuropsychological testing

KW - Self-report questionnaire

UR - http://www.scopus.com/inward/record.url?scp=85014468816&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1093/pm/pnv077

U2 - 10.1093/pm/pnv077

DO - 10.1093/pm/pnv077

M3 - Review article

VL - 17

SP - 1465

EP - 1489

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 8

ER -